Notably, an increasing number of studies have confirmed that the PI3K/AKT signaling pathway can be abnormally activated in a variety of cancer18–21, pulmonary fibrosis22,23, Alzheimer’s disease, and Parkinson’s disease24. Here, AKT1 is linked to Alzheimer disease.